| CARVIEW |
Select Language
HTTP/2 200
server: GitHub.com
content-type: text/html; charset=utf-8
x-origin-cache: HIT
last-modified: Fri, 24 May 2024 22:49:41 GMT
access-control-allow-origin: *
etag: W/"66511985-3f91"
expires: Sun, 01 Feb 2026 17:36:26 GMT
cache-control: max-age=600
content-encoding: gzip
x-proxy-cache: MISS
x-github-request-id: 2B8D:0A00:1B062D:1EFAC6:697F8CC2
accept-ranges: bytes
age: 0
date: Sun, 01 Feb 2026 17:26:26 GMT
via: 1.1 varnish
x-served-by: cache-bom-vanm7210060-BOM
x-cache: MISS
x-cache-hits: 0
x-timer: S1769966786.486803,VS0,VE222
vary: Accept-Encoding
x-fastly-request-id: 62d6d7fae6385e2f5d49b8c8efb5179e9a2a5ef7
content-length: 2911
Depth-First
Opting out of Optune
A treatment with small benefit and notable costs leads to a tough call.
Beating Swords into Ploughshares
A returning WWII veteran takes up an unlikely field of study.
Sowing Seeds on Rocky Soil
Tracing my physicist grandfather's origins to an unexpected place.
Grandpa, What Did You Do at the Atom Bomb Factory?
First in a series investigating what exactly my grandfather did at the Hanford Engineer works.
How I Bought and Estimated the Purity of Sodium Dichloroacetate
Trust, but verify. On second thought, just verify.
Beware Oncologists Bearing Hope
Why interpretations from this special breed of doctor should be considered carefully.
Just Saying "No" to Adjuvant Temozolomide
Discovering that the medicine cabinet for my terminal disease was filled with fluff.
Temodar, MGMT Methylation, and the Endless Loop of Bad Glioblastoma Treatments
Understanding why half of patients will take a drug offering little to no benefit.